🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Before Friday, I (perhaps naively) believed the NSC China team would be strengthened, while the NSC directorate for global health security and biodefense would be preserved. Instead, the reverse seems to be happening. ft.com/content/3a21c0… via @ft

LOL Hu Xijin, former editor-in-chief of state-owned newspaper Global Times: "Sexual recession is one of the important reasons behind China's sluggish consumption." He seems to get the logic backwards here - it's more likely that economic pressures and sluggish consumption are

Congrats, Suzanne!

- The X post highlights a historic drop in China's 2025 college entrance exam (gaokao) participants to 12.91 million, a decrease of 70,000 from 2024, despite a rising trend from 940,000 in 2015 to 13.42 million in 2024, as shown in the chart from Gelonghui. - The tweeter

Late 1978: The first group of Chinese scholars and students departed for the US, resuming educational exchanges after a long hiatus. Today: The USG says it will "aggressively revoke" Chinese student visas. Nearly 50 years later, we're back to square one. nytimes.com/2025/05/29/wor…

Shocking news: Bi Jingquan, former CFDA head, is under investigation for alleged serious disciplinary and legal violations. A surprising fall for the pharmaceutical reform titan who drove significant regulatory reforms that cleared drug approval backlogs, enhanced generic drug

According to a Chinese scholar, Bi Jingquan has made significant contributions in at least two areas. One is China's drug consistency evaluation, which was also the reason for his step-down. The other is the innovative drug market. The boom in Chinese innovative drugs, especially

China has surpassed the U.S. in clinical trials, listing over 7,100 in 2024 compared to the U.S.'s 6,000, and is leading in pharmaceutical patents and R&D infrastructure, driven by lower costs and streamlined regulations. This shift threatens U.S. dominance in biotech, as Chinese

Saw this title on Chinese media: "Trump's 'Academic Lockdown' Escalates, Global Top Scientists Accelerate 'Eastward Migration' to China." The first part might be true, but the claim of a mass "eastward migration" of top scientists to China is exaggerated and speculative, serving

A perspective worth noting: "as we look to the post-Trump future, it will be important for U.S. universities to recognize the genuine tensions and trade-offs of international enrollments, and to balance their increase with more outreach to a larger range of domestic applicants —

By the end of 2025, China is projected to have approximately 36-37 million unemployed college graduates, prompting Hong Kong-based scholar Ding Xueliang to propose recruiting 300,000 graduates annually into the military and organizing graduate teams by specialization to tackle

According to US intelligence company Morning Consult, China's global favorability rating has surpassed that of the United States for the 1st time in recent years, with China achieving a net rating of 8.8 compared to the US's -1.5 by late May—a dramatic reversal from Jan 2024 when

Yes. And we need to use DPA to get there if we’re about to lose IRA.

“It’s only a matter of time until China can develop these vaccines domestically—cheaper, faster, better, like it has done in other industries,” said Yanzhong Huang, a global-health expert at the Council on Foreign Relations. wsj.com/world/china/ch…

Yang Bin's claim that Covid-19 contains HIV gene fragments and could mutate into HIV is highly speculative and misleading. It’s concerning to see such assertions from someone affiliated with the prestigious Chinese Academy of Social Sciences, a key government think tank.

Zhou Xianwang, former Wuhan mayor during the 2020 COVID-19 outbreak, is under investigation for serious violations of discipline and law. His tenure as mayor drew scrutiny over delayed information disclosure during the early stages of the pandemic.